Original fundamental research starts and ENDS here.
Sectors Tags Blog
MDT
30 filings
Timeline Columns Start Research 8-K Categories
Earnings8 Executive Change6 Debt / Financing3 Shareholder Meeting2 M&A1
2025
Q4 4 filings
Nov
Q2 2026 Results
Financial data not accessible in provided format
10-Q
Nov
Q2 FY2026 Earnings
Second quarter fiscal year 2026 financial results announced
8-K
Nov
EVP Gregory Smith Retirement
Gregory L. Smith retiring Dec 2, 2025
8-K
Oct
Annual Shareholder Meeting
12 directors elected, Articles of Association amended
8-K
Q3 5 filings
Sep
Euro Debt Offering
€1.5B notes issued (€750M 2030 @ 2.95%, €750M 2045 @ 4.20%)
8-K
Sep
Euro Bond Issuance and Debt Redemption
€1.5B notes issued (€750M at 2.950% due 2030, €750M at 4.200% due 2045), redeeming €500M 2025 notes
8-K
Aug
Q1 2026 Results
Financial data not available in provided content
10-Q
Aug
2025 Proxy Statement
Annual Meeting: Oct 16, 2025, 12 director nominees, Say-on-pay proposal
DEF 14A
Aug
Q1 Earnings + Board Expansion
Q1 FY2026 results; Board expanded from 11 to 13 directors
8-K
Q2 3 filings
Jun
New Director Appointed
Dr. Joon Lee appointed to Board, expanding from 10 to 11 directors
8-K
Jun
FY 2025 Results
Unable to extract specific revenue and EPS figures from provided XBRL metadata
📌 Unable to identify specific milestones from provided XBRL taxonomy structure - actual financial data and narrative sections not included in extract
10-K
May
Q4 Earnings & Diabetes Spinoff
FY2025 results announced, Diabetes business separation into standalone public company
8-K
Q1 4 filings
Mar
Principal Accounting Officer Change
Jennifer Kirk resigns as Global Controller/PAO, Denise Blomquist appointed successor
8-K
Feb
Q3 2025 Results
Unable to extract specific revenue and EPS figures from provided XBRL tags
10-Q
Feb
Q3 FY2025 Earnings
Third quarter fiscal year 2025 financial results announced
8-K
Jan
CFO Appointment
Thierry Pieton named CFO effective March 3, 2025, $850K base salary
8-K
2024
Q4 3 filings
Nov
Q2 2025 Results
Unable to extract revenue and EPS figures from provided XBRL metadata
10-Q
Nov
Q2 FY2025 Earnings
Second quarter fiscal year 2025 financial results announced
8-K
Oct
Annual Shareholder Meeting
10 directors elected, auditor ratified, executive compensation approved
8-K
Q3 3 filings
Aug
Q1 2025 Results
Unable to extract specific revenue and EPS figures from provided XBRL data
10-Q
Aug
Q1 FY2025 Earnings
First quarter fiscal year 2025 financial results
8-K
Aug
2024 Proxy Statement
Annual General Meeting: Oct 17, 2024, 10 director nominees for election
DEF 14A
Q2 5 filings
Jun
CFO Departure
Karen Parkhill resigned effective Aug 2, Gary Corona named interim CFO
8-K
Jun
FY2024 Results
Unable to extract specific revenue and EPS figures from provided XBRL metadata
📌 Unable to identify specific milestone from provided XBRL metadata - document appears to contain only structural tags and filing references without actual financial values
10-K
Jun
EVP Rob ten Hoedt Retirement
Rob ten Hoedt, EVP & President Global Regions, retiring June 28, 2024
8-K
Jun
Euro Debt Offering
€3B notes issued across 4 tranches (2029-2053)
8-K
May
Q4 and Full Year FY2024 Earnings
Full year and fourth quarter fiscal year 2024 financial results announced
8-K
Q1 2 filings
Feb
Q3 2024 Results
Financial figures not available in provided excerpt
10-Q
Feb
Q3 Earnings & Executive Departure
Q3 FY2024 results + Robert J. White departing April 26
8-K
2023
Q4 1 filings
Dec
Terminated EOFlow Acquisition
Deal terminated due to multiple breaches by EOFlow
8-K
SECENDS is not affiliated with the SEC. Data from public EDGAR filings. Not financial advice.